JP2023540664A5 - - Google Patents
Info
- Publication number
- JP2023540664A5 JP2023540664A5 JP2022581404A JP2022581404A JP2023540664A5 JP 2023540664 A5 JP2023540664 A5 JP 2023540664A5 JP 2022581404 A JP2022581404 A JP 2022581404A JP 2022581404 A JP2022581404 A JP 2022581404A JP 2023540664 A5 JP2023540664 A5 JP 2023540664A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063046531P | 2020-06-30 | 2020-06-30 | |
| US63/046,531 | 2020-06-30 | ||
| PCT/US2021/039646 WO2022006129A1 (en) | 2020-06-30 | 2021-06-29 | Irak4 inhibitors and topical uses thereof |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023540664A JP2023540664A (ja) | 2023-09-26 |
| JP2023540664A5 true JP2023540664A5 (https=) | 2024-06-26 |
| JPWO2022006129A5 JPWO2022006129A5 (https=) | 2024-06-26 |
| JP7813733B2 JP7813733B2 (ja) | 2026-02-13 |
Family
ID=79315566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581404A Active JP7813733B2 (ja) | 2020-06-30 | 2021-06-29 | Ｉｒａｋ４阻害剤及びそれらの局所的使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230390265A1 (https=) |
| EP (1) | EP4172163A4 (https=) |
| JP (1) | JP7813733B2 (https=) |
| CN (1) | CN116134038A (https=) |
| AU (1) | AU2021300110A1 (https=) |
| BR (1) | BR112022027086A2 (https=) |
| CA (1) | CA3186630A1 (https=) |
| IL (1) | IL298929A (https=) |
| WO (1) | WO2022006129A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230125380A1 (en) * | 2019-11-05 | 2023-04-27 | Dermira, Inc. | Topical Compositions Comprising IRAK4 Inhibitors for Use in Treating Dermatological Conditions Characterised by Inflammation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102917751A (zh) * | 2010-05-28 | 2013-02-06 | 久光制药株式会社 | 具有带有微小突起的阵列的装置 |
| CN105899505B (zh) | 2013-11-08 | 2018-08-28 | 武田药品工业株式会社 | 用于治疗自身免疫病症的吡唑 |
| AR110250A1 (es) * | 2016-11-28 | 2019-03-13 | Aicuris Anti Infective Cures Gmbh | Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida |
| JP7108631B2 (ja) * | 2017-01-06 | 2022-07-28 | パルヴェラ セラピューティクス、インク． | ｍＴＯＲ阻害剤の無水組成物およびその使用方法 |
| WO2019143971A2 (en) * | 2018-01-18 | 2019-07-25 | Sienna Biopharmaceuticals, Inc. | Formulations for dermal delivery of polymer conjugates of indolocarbazole compounds with reduced exposure |
| RU2020130919A (ru) * | 2018-03-29 | 2022-04-29 | Лумоса Терапьютикс Ко., Лтд. | Композиции и способы для лечения зуда |
| AU2019290231A1 (en) * | 2018-06-21 | 2020-12-17 | Dermavant Sciences GmbH | Topical formulations of DGAT1 inhibitors and their methods of use |
| WO2020028820A1 (en) * | 2018-08-03 | 2020-02-06 | Aldeyra Therapeutics, Inc. | Topical compositions and methods of preparation and use |
| US20230125380A1 (en) * | 2019-11-05 | 2023-04-27 | Dermira, Inc. | Topical Compositions Comprising IRAK4 Inhibitors for Use in Treating Dermatological Conditions Characterised by Inflammation |
-
2021
- 2021-06-29 CA CA3186630A patent/CA3186630A1/en active Pending
- 2021-06-29 US US18/007,950 patent/US20230390265A1/en active Pending
- 2021-06-29 EP EP21832337.6A patent/EP4172163A4/en active Pending
- 2021-06-29 IL IL298929A patent/IL298929A/en unknown
- 2021-06-29 JP JP2022581404A patent/JP7813733B2/ja active Active
- 2021-06-29 WO PCT/US2021/039646 patent/WO2022006129A1/en not_active Ceased
- 2021-06-29 AU AU2021300110A patent/AU2021300110A1/en active Pending
- 2021-06-29 BR BR112022027086A patent/BR112022027086A2/pt unknown
- 2021-06-29 CN CN202180057708.9A patent/CN116134038A/zh active Pending